Maternal cardiovascular and endothelial function from first trimester to postpartum

Vassiliki Kolovetsiou-Kreiner, Manfred Georg Moertl, Ilona Papousek, Karin Schmid-Zalaudek, Uwe Lang, Dietmar Schlembach, Mila Cervar-Zivkovic, Helmut Karl Lackner, Vassiliki Kolovetsiou-Kreiner, Manfred Georg Moertl, Ilona Papousek, Karin Schmid-Zalaudek, Uwe Lang, Dietmar Schlembach, Mila Cervar-Zivkovic, Helmut Karl Lackner

Abstract

Objective: To explore noninvasively the complex interactions of the maternal hemodynamic system throughout pregnancy and the resulting after-effect six weeks postpartum.

Methods: Eighteen women were tested beginning at the 12th week of gestation at six time-points throughout pregnancy and six weeks postpartum. Heart rate, heart rate variability, blood pressure, pulse transit time (PTT), respiration, and baroreceptor sensitivity were analyzed in resting conditions. Additionally, hemoglobin, asymmetric and symmetric dimethylarginine and Endothelin (ET-1) were obtained.

Results: Heart rate and sympathovagal balance favoring sympathetic drive increased, the vagal tone and the baroreflex sensitivity decreased during pregnancy. Relative sympathetic drive (sympathovagal balance) reached a maximum at 6 weeks postpartum whereas the other variables did not differ compared to first trimester levels. Postpartum diastolic blood pressure was higher compared to first and second trimester. Pulse transit time and endothelial markers showed no difference throughout gestation. However, opposing variables PTT and asymmetric dimethylarginine (ADMA) were both higher six weeks postpartum.

Conclusions: The sympathetic up regulation throughout pregnancy goes hand in hand with a decreased baroreflex sensitivity. In the postpartum period, the autonomic nervous system, biochemical endothelial reactions and PTT show significant and opposing changes compared to pregnancy findings, indicating the complex aftermath of the increase of blood volume, the changes in perfusion strategies and blood pressure regulation that occur in pregnancy.

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. Duvekot JJ, Peeters LL. Maternal cardiovascular hemodynamic adaptation to pregnancy. Obtstet Gynecol Surv. 1994. December 8;:1–14.
    1. Abbas AE, Lester SJ, Connolly H. Pregnancy and the cardiovascular system. International Journal of Cardiology. 2005. February;98(2):179–89. doi:
    1. Macedo ML, Luminoso D, Savvidou MD, McEniery CM, Nicolaides KH. Maternal Wave Reflections and Arterial Stiffness in Normal Pregnancy as Assessed by Applanation Tonometry. Hypertension. 2008. March 19;51(4):1047–51. doi:
    1. Ouzounian JG, Elkayam U. Physiologic Changes During Normal Pregnancy and Delivery. Cardiology Clinics. 2012. Aug;30(3):317–29. doi:
    1. Capeless EL, Clapp JF. When do cardiovascular parameters return to their preconception values? YMOB. 1991. October;165(4 Pt 1):883–6.
    1. Ekholm EM, Erkkola RU. Autonomic cardiovascular control in pregnancy. Eur J Obstet Gynecol Reprod Biol. 1996. January;64(1):29–36.
    1. Fu Q, Levine B. Autonomic Circulatory Control during Pregnancy in Humans. Semin Reprod Med. 2009. June 15;27(04):330–7. doi:
    1. Moertl MG, Lackner HK, Papousek I, Roessler A, Hinghofer-Szalkay H, Lang U, et al. Phase Synchronization of Hemodynamic Variables at Rest and after Deep Breathing Measured during the Course of Pregnancy. Bader M, editor. PLoS ONE. 2013. April 5;8(4):e60675 doi:
    1. Maeda T, Yoshimura T, Okamura H. Asymmetric dimethylarginine, an endogenous inhibitor ofnitric oxide synthase, in maternal and fetal circulation. Journal Soc Gynecol Investig. January;10(1):2–4.
    1. Dayoub H. Achan V, Adimoolam S, Jacobi J, Stuehlinger MC, Wang BY, et al. Dimethylarginine Dimethylaminohydrolase Regulates Nitric Oxide Synthesis: Genetic and Physiological Evidence. Circulation. 2003. December 16;108(24):3042–7. doi:
    1. Khalil A, Hardman L, Brien PO. The role of arginine, homoarginine and nitric oxide in pregnancy. Amino Acids. Springer Vienna; 2015. June 19;47(9):1715–27. doi:
    1. Fortin J, Marte W, Grüllenberger R, Hacker A, Habenbacher W, Heller A, et al. Continuous non-invasive blood pressure monitoring using concentrically interlocking control loops. Computers in Biology and Medicine. 2006. September;36(9):941–57. doi:
    1. Lackner HK, Batzel JJ, Rössler A, Hinghofer-Szalkay H, Papousek I. Multi-time scale perspective in analyzing cardiovascular data. Physiol Res. 2014;63(4):439–56.
    1. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Vol. 93, Circulation. 1996. pp. 1043–65.
    1. Parati G, Omboni S, Frattola A, Di Rienzo M, Zanchetti A, Mancia G. Dynamic evaluation of the baroreflex in ambulant subject. In: DiRienzo M, Mancia G, Parati G, Pedotti A, Zanchetti A. (eds), Blood Pressure and Heart Rate Variability. Amsterdam: IOS Press. 1992;:123–37.
    1. Mahendru AA, Everett TR, Wilkinson IB, Lees CC, McEniery CM. Maternal cardiovascular changes from pre-pregnancy to very early pregnancy. Journal of Hypertension. 2012. November;30(11):2168–72. doi:
    1. Mabie WC, DiSessa TG, Crocker LG, Sibai BM, Arheart KL. A longitudinal study of cardiac output in normal human pregnancy. YMOB. 1994. March;170(3):849–56.
    1. Ekholm EM, Erkkola RU, Piha SJ, Jalonen JO, Metsälä TH, Antila KJ. Changes in autonomic cardiovascular control in mid-pregnancy. Clin Physiol. 1992. September;12(5):527–36.
    1. Ekholm EM, Piha SJ, Antila KJ, Erkkola RU. Cardiovascular autonomic reflexes in mid-pregnancy. Br J Obstet Gynaecol. 1993. Feb;100(2):177–82.
    1. Lucini D, Strappazzon P, Dalla Vecchia L, Maggioni C, Pagani M. Cardiac autonomic adjustments to normal human pregnancy: insight from spectral analysis of R-R interval and systolic arterial pressure variability. Journal of Hypertension. 1999. December;17(12 Pt 2):1899–904.
    1. Voss A, Malberg H, Schumann A, Wessel N, Walther T, Stepan H, Faber R. Baroreflex sensitivity, heart rate, and blood pressure variability in normal pregnancy. Am J Hypertens. 2000. November;13(11):1218–25.
    1. Baumert M, Javorka M, Seeck A, Faber R, Sanders P, Voss A. Multiscale entropy and detrended fluctuation analysis of QT interval and heart rate variability during normal pregnancy. Comput Biol Med. 2012. March;42(3):347–52. doi:
    1. Walther T, Voss A, Baumert M, Truebner S, Till H, Stepan H, Wessel N, Faber R. Cardiovascular variability before and after delivery: recovery from arterial stiffness in women with preeclampsia 4 days post partum. Hypertens Pregnancy. 2014. February;33(1):1–14. doi:
    1. Eneroth E, Westgren M, Ericsson M, Lindblad LE, Storck N. 24-hour ECG frequency-domain measures in preeclamptic and healthy pregnant women during and after pregnancy. Hypertens Pregnancy. 1999;18(1):1–9.
    1. Murphy MS, Seaborn GE, Redfearn DP, Smith GN. Reduced Heart Rate Variability and Altered Cardiac Conduction after Pre-Eclampsia. PLoS One. 2015. September 25;10(9):e0138664 doi: .
    1. Foo JY, Lim CS. Pulse transit time as an indirect marker for variations incardiovascular related reactivity. Technol Health Care. 2006;14(2):97–108.
    1. Sakurai M, Yamakado T, Kurachi H, Kato T, Kuroda K, Ishisu R, et al. The relationship between aortic augmentation index and pulse wave velocity: an invasive study. Journal of Hypertension. 2007. February;25(2):391–7. doi:
    1. Su F, Li Z, Sun X, Han N, Wang L, Luo X. The pulse wave analysis of normal pregnancy: investigating the gestational effects on photoplethysmographic signals. Biomed Mater Eng. 2014;24(1):209–19. doi:
    1. Tomsin K. The maternal venous system: the ugly duckling of obstetrics. Facts Views Vis Obgyn. 2013;5(2):116–23.
    1. Khalil A, Akolekar R, Syngelaki A, Elkhouli M, Nicolaides KH. Maternal Hemodynamics in Normal Pregnancies at 11–13 Weeks’ Gestation. Fetal Diagn Ther. 2012;32(3):179–85. doi:
    1. Goldoozian LS, Zahedi E, Zarzoso V. Time-varying assessment of heart rate variability parameters using respiratory information. Comput Biol Med. 2017. October 1;89:355–367. doi:
    1. Blake MJ, Martin A, Manktelow BN, Armstrong C, Halligan AW, Panerai RB, et al. Changes in baroreceptor sensitivity for heart rate during normotensive pregnancy and the puerperium. Clin Sci. 2000. March;98(3):259–68.
    1. Seligman SA. Baroreceptor reflex function in pre-eclampsia. J Obstet Gynaecol Br Commonw. 1971. May;78(5):413–6.
    1. Leduc L, Wasserstrum N, Spillman T, Cotton DB. Baroreflex function in normal pregnancy. YMOB. 1991. October;165(4 Pt 1):886–90.
    1. Miyake Y, Ohnishi M, Fujii TK, Yamamoto T. The effects of postural changes of baroreflex gain in normal and hypertensive pregnancies. Clin Exp Hypertens. 2002. Jan-Feb;24(1–2):23–31.
    1. Valdes G, Salas SP, Foradori AC, Gormaz G, Croxatto HR. The neurogenic response to 55-degree head-up tilt in normal pregnant women. Vol. 8 Hypertension; 1986. May pp. 1–1.
    1. Böger RH. Arginine metabolism: enzymology, nutrition, and clinical significance. Proceedings of a symposium dedicated to the memory of Vernon R. Young. April 5–6, 2004. Bermuda. J Nutr. 2004. October;134(10 Suppl):2741S–2897S.
    1. Vallance P, Moncada S, Calver A, Collier J. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 1992. March 7;339(8793):572–5.
    1. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheralarteriolar tone in man. Lancet. 1989. October 28; 2(8670):997–1000.
    1. Cameron IT, Bacon CR, Collett GP, Davenport AP. Endothelin expression in the uterus. J Steroid Biochem Mol Biol. 1995. June;53(1–6):209–14.
    1. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, et al. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA. 1989. April;86(8):2863–7.
    1. Ajne G, Ahlborg G, Wolff K, Nisell H. Contribution of endogenous endothelin-1 to basal vascular tone during normal pregnancy and preeclampsia. American Journal of Obstetrics and Gynecology. 2005. July;193(1):234–40. doi:
    1. Lucovnik M, Lackner HK, Papousek I, Schmid-Zalaudek K, Schulter G, Roessler A, Moertl MG. Systemic vascular resistance and endogenous inhibitors of nitric oxide synthesis in early- compared to late-onset preeclampsia: preliminary findings. Hypertens Pregnancy. 2017. August;36(3):276–281. doi:
    1. Rizos D, Eleftheriades M, Batakis E, Rizou M, Haliassos A, Hassiakos D, et al. Levels of asymmetric dimethylarginine throughout normal pregnancy and in pregnancies complicated with preeclampsia or had a small for gestational age baby. J Matern Fetal Neonatal Med. 2012. Aug;25(8):1311–5. doi: .
    1. Holden DP, Fickling SA, Whitley GS, Nussey SS. Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia. YMOB. 1998. March;178(3):551–6.
    1. Valtonen P, Punnonen K, Saarelainen H, Heiskanen N, Raitakari OT, Viikari JSA, et al. Maternal serum ADMA is not associated with proinflammatory cytokines or C-reactive protein during normal pregnancy. Cytokine. Elsevier Ltd; 2009. May 1;46(2):216–21. doi: .
    1. Slaghekke F, Dekker G, Jeffries B. Endogenous inhibitors of nitric oxide and preeclampsia: a review. J Matern Fetal Neonatal Med. 2006. August;19(8):447–52. doi:
    1. Braekke K, Ueland PM, Harsem NK, Staff AC. Asymmetric dimethylarginine in the maternal and fetal circulation in preeclampsia. Pediatr Res. 2009. October;66(4):411–5. doi:

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel